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To establish pathogenicity, bacteria must evade
phagocytosis directed by remodeling of the actin
cytoskeleton. We show that macrophages facilitate
pathogen phagocytosis through actin polymeriza-
tion mediated by the WAVE regulatory complex
(WRC), small GTPases Arf and Rac1, and the Arf1
activator ARNO. To establish extracellular infec-
tions, enteropathogenic (EPEC) and enterohaemor-
rhagic (EHEC) Escherichia coli hijack the actin cyto-
skeleton by injecting virulence effectors into the
host cell. Here, we find that the virulence effector
EspG counteracts WRC-dependent phagocytosis,
enabling EPEC and EHEC to remain extracellular.
By reconstituting membrane-associated actin poly-
merization, we find that EspG disabled WRC activa-
tion through two mechanisms: EspG interaction
with Arf6 blocked signaling to ARNO while EspG
binding of Arf1 impeded collaboration with Rac1,
thereby inhibiting WRC recruitment and activation.
Investigating the mode of EspG interference re-
vealed sites in Arf1 required for WRC activation
and a mechanism facilitating pathogen evasion of
innate host defenses.INTRODUCTION
Professional phagocytes cells represent the first line of host
defense against bacterial pathogens. To eradicate pathogenic
bacteria, professional phagocytes employ myriad host cell-
surface receptors that bind the target bacterium directly
(e.g., bacterial surface sugars) or indirectly through host-
derived opsonins (e.g., antibodies, complement) (Celli and
Finlay, 2002; Sarantis and Grinstein, 2012). Receptor binding
triggers polymerization of actin filaments that guide the
plasma membrane around the pathogen to facilitate bacterial
uptake and destruction within an intracellular microbicidal
phagolysosome compartment. The actin polymerization re-
quires Rho GTPases Rac1 and Cdc42 that anchor by lipidCell Re
This is an open access article undprenylation to the membrane where they recruit and activate
myriad cellular effectors responsible for directing cytoskel-
eton remodeling via the Arp2/3 complex (Caron and Hall,
1998; May et al., 2000).
Counteracting phagocytosis is a central paradigm in bacterial
pathogenicity. For example, to inhibit opsonin-dependent trans-
phagocytosis Staphylococcus aureus secretes protein A, which
sequesters antibodies, while several pathogens use cell-surface
capsule polysaccharides to inhibit deposition of complement
(Celli and Finlay, 2002; Sarantis and Grinstein, 2012). However,
phagocytes offset this strategy through myriad non-opsononic
phagocyte receptors that directly bind bacteria and mediate
cis-phagocytosis independent of opsonins. Nevertheless, unit-
ing the diverse uptake mechanisms is the role of the actin cyto-
skeleton whose remodeling is required for phagocytosis (May
et al., 2000). Consequently, pathogens have evolved sophisti-
cated measures to interfere with the actin cytoskeleton and
antagonize a spectrum of phagocytic mechanisms at the mole-
cular level.
Enteropathogenic and enterohaemorrhagic Escherichia coli
(EPEC and EHEC) aremajor global human health threats causing
gastroenteritis and bloody diarrhea, respectively (Hartland and
Leong, 2013). To cause disease, they inject a cocktail of viru-
lence effectors into host cells via a type 3 secretion system
(T3SS) to enable cell-surface colonization on intestinal epithelia
where the pathogen forms lesions characterized by the destruc-
tion of brush border microvillii. Here, the bacteria encounter
macrophages that infiltrate sites of infection yet EPEC and
EHEC are able to block their own phagocytosis through the in-
jected virulence effectors (Santos and Finlay, 2015). Indeed, mu-
tants of type 3 secretion are phagocytosed by macrophages
(Goosney et al., 1999;Marche`s et al., 2008). Four virulence effec-
tors are known to contribute to anti-phagocytosis (Santos and
Finlay, 2015); EspB interacts with the actin binding motor protein
myosin-1c (Iizumi et al., 2007), EspF inhibits PI3 kinase signaling
(Celli et al., 2001), EspH inhibits the Dbl subfamily of Rho guanine
nucleotide exchange factors (GEFs) (Dong et al., 2010) and EspJ
impedes phagocytosis through inhibition of Src kinase activity
(Young et al., 2014).
EPEC and EHEC employ multiple mechanisms to disable
phagocytosis. While it is clear that the pathogens target the actin
cytoskeleton, we do not yet understand the identity of the cellular
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and therefore the mechanisms of bacterial interference. Conse-
quently, we first sought to identify the players underlying the
actin filament polymerization that are targeted by virulence
effectors.
RESULTS
EPEC Opposes Phagocytosis Directed by the WAVE
Regulatory Complex
To address how pathogenic Escherichia coli resist engulfment
by macrophages, we infected differentiated human THP1
macrophage cells with wild-type EPEC (EPECWT) or T3SS-defi-
cient mutant EPEC (EPECDT3SS) labeled with pHrodo, a pH-sen-
sitive dye that fluoresces red in the low pH of phagosomes and
signified pathogen uptake (Figure 1A). Intracellular bacteria
were inaccessible to antibodies against EPEC that marked
extracellular bacteria. Only 27% of EPECWT were found intra-
cellular within phagosomes of host cells (actin) and labeling of
extracellular bacteria with antibodies demonstrated that the
majority of bacteria had counteracted phagocytosis (Figures
1A and 1B). In contrast, very few extracellular EPECDT3SS were
observed as 92% of bacteria had been phagocytosed. Equiv-
alent results were observed in RAW267.4 mouse macrophage
cells (Figure S1A), confirming that EPEC fights phagocytosis
using T3SS effectors.
Given the central role of Arp2/3-dependent actin polymeriza-
tion in phagocytosis (May et al., 2000), it seemed likely that
EPEC targeted activators of Arp2/3. The WAVE regulatory com-
plex (WRC) is one such activator that is known to drive pathogen
macropinocytosis in epithelial cells (Humphreys et al., 2012b,
2013) and has been implicated in phagocytosis by Dictyostelium
(Seastone et al., 2001), mammalian granulocytes (Pils et al.,
2012), and neutrophils and macrophages (Park et al., 2008).
The WRC is a heteropentameric complex comprising Cyfip,
Nap/Hem, Abi, and HSPC300 or their homologs (Gautreau
et al., 2004), which must be activated directly by Rac1 (Miki
et al., 1998) in combination with additional potentiating signals
including that mediated directly by Arf1 GTPase (Koronakis
et al., 2011; Krause and Gautreau, 2014). Though whether
Rac1 and Arf1 co-operate in WRC-mediated phagocytosis is
not known.
To address whether EPEC effectors resist WRC-dependent
phagocytosis, THP1 macrophages were depleted of the WRC
component Hem by siRNA knockdown before infection with
EPECDT3SS (Figures 1C, S1B, and S1C). In contrast to mock
knockdown cells where 84% of EPECDT3SS were phagocy-
tosed (Figures 1C, S1B, and S1C), pathogen uptake was signif-
icantly impaired in Hem knockdown cells where it was reduced
to 33% with the majority of bacteria observed extracellularly
(Figures 1C and S1C). Little is known about WRC regulation in
macrophages, and we sought to address the significance of
co-operating small GTPases Arf1 and Rac1. Here, knockdown
of WRC activators Arf1 and Rac1 also reduced EPECDT3SS up-
take to 38% and 35%, respectively (Figure 1C), which
enabled bacteria to remain on the cell surface (Figure S1C) and
established that EPEC effectors oppose WRC-dependent
phagocytosis regulated by cooperating small GTPases Arf1
and Rac1.698 Cell Reports 17, 697–707, October 11, 2016EPEC Effector EspG Disables WAVE Regulatory
Complex Activation
Given the prominent role of small GTPases in EPECDT3SS phago-
cytosis, we reasoned that EPEC effectors might directly target
these players to resist uptake. This strategy is a central virulence
strategy employed by many pathogens that deactivate small
GTPases through effectors possessing GTPase-activating activ-
ity that promote GTP hydrolysis (Dean, 2011). Even so, EPEC en-
codes no known GTPase-activating protein (GAP) of Rac1 or
Arf1 and therefore likely uses an alternative mechanism. One
possibility included the EPEC effector EspG that was previously
shown to act as a molecular scaffold by simultaneously binding
the Rac1 effector p21 activated kinase (PAK) andGTP-bound Arf
GTPases (e.g., Arf1, Arf6) (Selyunin et al., 2011). EspG directly
activates PAK, while EspG interaction with Arf sterically hinders
Arf GAPs, thereby maintaining the GTP-bound form of Arf,
which still has portions of its switch 1 and 2 domains exposed
to permit interactions with some, but not all, of its cellular effec-
tors (Selyunin et al., 2011, 2014).
First, we examined whether EspG antagonizes WRC-depen-
dent cytoskeleton remodeling by infecting THP1 macrophages
with pHrodo-labeled EPECWT or an isogenic strain with null
mutations in espG and its close homolog espG2, henceforth
EPECDespG (Figure 1D). In contrast to wild-type bacteria,
EPECDespG bacteria were incapable of resisting phagocytosis,
and 85% were observed intracellularly mirroring the phagocy-
tosis of EPECDT3SS (Figures 1B and 1D). Furthermore, this EspG
role appears conserved as DespG strain of the related pathogen
EHECwas also susceptible to phagocytic uptake while wild-type
EHEC were resistant (Figure S1D).
We next investigated the mechanism of WRC interference by
EspG. The phosphoinositide PIP3 is known to activate the
WRC through Rac1 and Arf GTPases (Lebensohn and Kirsch-
ner, 2009; Koronakis et al., 2011), and PIP3 is a major regulator
of pathogen phagocytosis (Cox et al., 1999; Celli et al., 2001;
Quitard et al., 2006), but how EPEC counteracts PIP3-driven
pathways is unclear. We first reconstituted WRC-dependent
actin polymerization driven by PIP3 using a motility assay in
cell-free extracts as previously described (Hume et al., 2014).
Silica microspheres coated with a phospholipid bilayer con-
taining equal amounts of phosphatidylcholine (PC) and phos-
phatidylinositol (PI) plus 2% PIP3 (PIP3) were added to cell-
free extract containing fluorescent rhodamine-labeled actin
and non-hydrolysable GTPgS to activate GTPases. In the con-
trol, PIP3 microspheres triggered actin polymerization and
generated actin-comet tails (of 14 mm) on the membrane sur-
face that propelled the beads through the extract (Figure 1E).
When PIP3-driven motility was examined in extract containing
purified recombinant EspG, actin comet tail formation was
abrogated and there was no actin assembly on the membrane
surface (+EspG). This mirrored the phenotype observed with a
Rac1 inhibitor (EHT1864) (Figure 1E) indicating EspG inhibition
of the WRC.
To demonstrate that EspG was blocking WRC activation by
Arf1 and Rac1, PC:PI microspheres (i.e., without PIP3) were
anchored with purified constitutively active GTP-bound myris-
toylated Arf1-Q71L (Arf1QL) and prenylated Rac1-Q61L (Rac1QL)
and then added to cell-free extract in the presence or absence of
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Figure 1. EspG Interference of the WAVE Regulatory Complex
(A) Phagocytosis of pH-Rodo-labeled wild-type and DT3SS EPEC. Merged images show intracellular bacteria (red), extracellular bacteria (blue), and host cells
(actin). Grayscale shown for clarity. Scale bars, 6 mm.
(B) Bar chart quantifying phagocytosis from experiment in (A).
(C) Phagocytosis of EPECDT3SS (DT3SS) in THP1s transfected with Hem, Rac1, or Arf1 siRNA.
(D) Phagocytosis of EPECDespG (DespG). Asterisks indicate a significant difference from control (black bars).
(E) Actin-basedmotility of PIP3-containing microspheres (depicted in cartoon) in cell-free extract containing a Rac1 inhibitor (+EHT1864) or EspG. Insets magnify
actin-comet tails. Scale bars, 5 mm.
(F) WRC-dependent actin-based motility of PC:PI phospholipid bilayers microspheres co-anchored with Arf1QL and Rac1QL in cell-free extract containing
fluorescent rhodamine-actin in the presence (+EspG) or absence (control) of recombinant EspG.
(G) Proteins recruited by PC:PI-coated microspheres alone (control) or co-anchored with Arf1QL and Rac1QL (colored circles) from extract (–/+ EspG) were
analyzed by SDS-PAGE and Coomassie blue staining. Green arrows indicate cyfip, Hem, or actin. Orange arrows indicate absence of cyfip and Hem. Molecular
weight markers in kilodaltons (left).
(H) Immunoblotting of samples from (G) with indicated antibodies (right).
In bar charts (B)–(D), error bars represent ± SEM. See also Figure S1.EspG (Figure 1F). WRC-dependent actin comet tail formation
(15 mm) was observed in extracts containing PC:PI micro-
spheres co-anchored with Arf1QL and Rac1QL, but actin poly-
merization was abolished in extract containing EspG.To further examine how EspG disables WRC-dependent actin
polymerization, we scaled up the motility assays to isolate the
components recruited to the membrane co-anchored with
Arf1QL and Rac1QL in the presence or absence of EspG (FiguresCell Reports 17, 697–707, October 11, 2016 699
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Figure 2. EspG Interaction with Arf GTPase Blocks the WRC
(A) Cartoon depicting key residues (white) in EspG (black) responsible for interaction with Rabs (green), PAK (blue), or Arf (purple).
(B) WRC-dependent actin-based motility via membrane-anchored Arf1QL and Rac1QL (depicted in cartoon) alone (control) or in the presence of EspG, namely,
wild-type (WT) or mutants in binding Rab (EspGDR), PAK (EspGDP) or both Arf and PAK (EspGDADP).
(C) Interaction of EspG derivatives with membrane-anchored Arf1QL in buffer.
(D) Proteins recruited bymembrane-anchored Arf1QL and Rac1QL (colored circles) in the presence or absence of EspG derivatives as (B) analyzed by SDS-PAGE.
Molecular weight markers in kilodaltons (left).
(E) Immunoblotting of samples from (D) with indicated antibodies (right).
(F) Phagocytosis of EPECDespG (DespG) expressing a control vector or the vector encoding espG variants described in (B).
Error bars represent ± SEM. Asterisks indicate a significant difference from control (black bars). ns, not significant. See also Figure S2.1G and 1H). PC:PI microspheres alone (control) or co-anchored
with Arf1QL and Rac1QL were each incubated in cell-free extract
with or without recombinant EspG before being isolated and
extensively washed then recruited proteins analyzed by SDS-
PAGE and immunoblotting (Figures 1G and 1H). Control micro-
spheres (–) only recruited non-specific proteins, which was
also the case when EspG was present (Figures 1G and 1H). In
contrast, microspheres co-anchored with Arf1QL and Rac1QL re-
cruited the WRC components cyfip and Hem (Figure 1G, green
arrows). Their recruitment was confirmed by immunoblotting
(Figure 1H), which also verified the presence of WRC compo-
nents WAVE and abi1, small GTPases Arf1 and Rac1, and actin
derived from comet tails. In contrast, WRC recruitment was
impeded (orange arrows) by EspG that was found localized at
the membrane, which was dependent upon Arf1QL and Rac1QL
(Figures 1G and 1H). Thus, EspG impedes WRC recruitment
and activation, PIP3-mediated actin filament polymerization,
and WRC-dependent phagocytosis of EPEC and EHEC.
EspG Targeting of Arf1 Antagonizes WRC-Mediated
Phagocytosis
EspG is a multifunctional virulence effector and may interfere
with WRC-mediated cytoskeleton remodeling in several ways:
EspG binds active Arf GTPases and deactivates Rab GTPases
(Selyunin et al., 2011; Dong et al., 2012), and both Arf and Rab
GTPases are known to promote Rac1-dependent actin filament700 Cell Reports 17, 697–707, October 11, 2016polymerization (Palamidessi et al., 2008; Koronakis et al., 2011).
EspG also activates PAK (Selyunin et al., 2011) that modulates
actin filament dynamics, e.g., by deactivating cofilin (Edwards
et al., 1999). Consistent with a possible role for PAK1, the pres-
ence of EspG at membranes co-anchored with Arf1QL and
Rac1QL was co-incident with enhanced PAK1 recruitment
(Figure 1H).
To resolve how EspG disables WAVE complex activation, we
first purified recombinant EspG mutants (Figure 2A) incapable
of deactivating Rabs (EspGDR; mutation Q293A) (Dong et al.,
2012), binding PAK (EspGDP; D205A, R208A) (Germane and
Spiller, 2011), or binding Arf and PAK (EspGDADP; I152S,
P351A, P355A) (Selyunin et al., 2011) before assessing interfer-
ence with WRC-dependent actin-based motility directed by
Arf1QL and Rac1QL (Figure 2B). Like EspGWT, mutant derivatives
EspGDR and EspGDP both abrogated actin-comet tail formation
showing that EspG interaction with PAK and its Rab GAP activity
were dispensable for WRC inhibition. This was not the case for
EspGDADP, which had no effect on WRC activity as actin comet
tails (of 14 mm as control) were formed and the microspheres
moved through the extract. Thus, EspG targeting of Arf1 and
not PAK or Rabs blocked WRC activation.
Consistent with this view, only EspGDADP was deficient in
binding Arf1QL-anchored membranes in buffer (Figure 2C).
Moreover, when EspGWT was pre-incubated with membranes
co-anchored with Arf1QL and Rac1QL to form an Arf1-EspG
complex before incubation in extract, WRC-dependent actin
comet tail formation was not observed (data not shown). Further-
more, chemical inhibitors of PAK (i.e., IPA3) have been shown to
inhibit activation by EspG (Selyunin et al., 2011), yet WRC-
dependent actin-based motility was observed in PAK-inhibited
extract (Figure S2B), reaffirming that EspG inhibits the WRC
independently of PAK.
To further examine EspG inhibition of the WRC, we assessed
WRC recruitment by Arf1QL and Rac1QL from cell extract in the
presence of the EspG derivatives (Figures 2D and 2E). WRC
recruitment to the membrane was obstructed by EspGWT,
EspGDR, and EspGDP but not EspGDADP as exemplified by the
SDS-PAGE (Figure 2D, green arrows) and immunoblotting of
Hem (Figure 2E). All EspG variants except EspGDADP were re-
cruited to Arf1QL and Rac1QL co-anchoredmembranes. Interest-
ingly, EspGDP but not EspGDADP recruited PAK1 indicating that
PAK recruitment was dependent upon the Arf1-EspG interaction
and localization of the virulence effector at the membrane.
In parallel, we assessed phagocytic uptake of EPECDespG ex-
pressing either EspGWT, EspGDR, EspGDP, EspGDADP, or the
empty vector as a control (Figures 2F and S2A). THP1 macro-
phages phagocytosed82%of EPECDespG encoding the vector
alone, while bacteria expressing EspGWT resisted WRC-depen-
dent uptake that was reduced to 35% (Figures 2F and S2A),
mirroring the resistance imposed by wild-type EPEC (Figure 1).
Similarly, EPECDespG expressing EspGDR or EspGDP also antag-
onized phagocytosis. In contrast, 79% of bacteria expressing
EspGDADP were incapable of resisting the WRC and were
phagocytosed to the same extent as the EPECDespG vector con-
trol strain. Thus, EspG-mediated interaction with Arf GTPases,
and not PAK or Rabs, combats WRC-directed pathogen
phagocytosis.
Next, we examined whether EspG could counteract the
activities of other pathogens dependent upon the WRC. In
contrast to extracellular pathogens EPEC and EHEC, Salmonella
Typhimurium is an intracellular pathogen that invades host
epithelial cells by activating the WRC-Rac1-Arf1 axis (Hum-
phreys et al., 2012b, 2013). When we examined Salmonella
invasion in HeLa cells expressing HA-tagged EspG, pathogen
uptake was reduced by 64% relative to control, which was
not observed in cells expressing EspGDADP (Figure 3A), thus
providing further evidence of EspG interference of WRC-depen-
dent cytoskeleton remodeling.
EspG Incapacitates Arf6 and ARNO Upstream of WRC
Activation
EspG is known to bind Arf6 in an analogous fashion to Arf1 (Se-
lyunin et al., 2011), though no function has been ascribed for this
host-pathogen interaction. To trigger WRC-dependent invasion,
Salmonella Typhimurium hijacks Arf6 to recruit and activate the
Arf1 GEF ARNO of the cytohesisn family (Humphreys et al.,
2013; Stalder et al., 2011). We therefore speculated that EspG
might also incapacitate WRC activation by inhibiting Arf6 up-
stream of ARNO-mediated activation of Arf1.
First, we examined whether the cytohesin family (i.e., ARNO)
facilitated phagocytosis. THP1 cells treated with the cytohesin
inhibitor secinh3 impeded the relative uptake of EPECDespG
from 82% to 30% (Figures 3B and 3C). ARNO is known tofacilitate macropinocytosis (Humphreys et al., 2012b, 2013),
but the uptake of EPECDespG was not affected by the macropi-
nocytosis inhibitor eipa (Figure 3B). Secinh3 but not eipa also
inhibited the phagocytosis of EPECDespG opsonized with human
serum (Figure S2C). Thus, ARNO directs phagocytosis of EPEC,
which was counteracted by EspG.
We next examined the mechanism by which EspG antago-
nized ARNO by reconstituting Arf6-driven activation of WRC as
previously reported (Humphreys et al., 2013). PC:PI micro-
spheres anchored with recombinant myristoylated Arf6 acti-
vated with GTPgS were incubated in extract with or without (–)
recombinant ARNO (Figure 3D). Arf6 only triggered actin assem-
bly in the presence of ARNO, but this was abrogated in extract
containing EspGWT but not EspGDADP. To determine how
EspG impeded Arf6-dependent actin polymerization, PC:PI
microspheres were isolated from extract then analyzed by
immunoblotting (Figure 3E). To trigger WRC activation, Arf6
must recruit ARNO (Humphreys et al., 2013). Indeed, Arf6 alone
(– ARNO) recruited very little Arf1 and Hem, which was enhanced
upon addition of recombinant ARNO (+ ARNO). However, in the
presence of EspG, Arf6 was incapacitated as the recruitment of
ARNO as well as downstream players Arf1 and Hem were
impeded. This was not the case with the Arf binding mutant
EspGDADP that had no effect on the Arf6 cascade.
Finally, to investigate whether EspG directly inhibits ARNO via
binding to Arf6, we examined interactions in buffer with purified
components and PC-coated microspheres (Figures 3F and 3G)
that minimize known ionic interactions between the ARNO plek-
strin-homology domain and acidic phospholipids such as PI
(Macia et al., 2000). ARNO weakly bound PC microspheres
alone, but its recruitment was potentiated by Arf6 (Figures 3F
and 3G). In the presence of EspGWT, the virulence effector was
recruited through Arf6 that blocked interaction with ARNO (Fig-
ures 3F and 3G). In contrast, the Arf binding mutant EspGDADP
was not recruited by Arf6 and was incapable of impeding
ARNO (Figures 3F and 3G). Thus, EspG directly disables Arf6-
dependent actin polymerization by blocking signaling to its
cellular effector ARNO.
The Molecular Basis of WRC Interference by EspG
Activated Arf1 mediates interaction with cellular effectors via its
switch 1 (residues 40–51) and 2 (68–81) domains (Nie et al.,
2003). EspG exhibits an unusual Arf binding interface that is
rotated away from the switch 2 site (Figure 4A) where it interacts
with the switch 1 and the alpha-1 helix (29-37) positioned outside
of the canonical switch regions (Selyunin et al., 2011). Conse-
quently, Arf1 bound to EspG can still bind cellular effectors
that interact with its switch 2 domain such as the Arf binding
GAT domain of GGA vesicle adaptors (Selyunin et al., 2014;
Kuai et al., 2000) as depicted in Figure 4A and confirmed exper-
imentally in Figure S3A.
We took advantage of the distinct binding modes of EspG and
GAT3 to investigate the mechanism of Arf1-mediated WRC acti-
vation and EspG interference. First, we examined actin-based
motility in extracts containing equivalent concentrations of either
EspG or GAT3 (Figure 4B). EspG was more potent at inhibiting
WRC than GAT3, which impeded robust comet tail formation
but still permitted initiation of actin assembly and small cometCell Reports 17, 697–707, October 11, 2016 701
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Figure 3. EspG Incapacitation of Arf6 Signaling to ARNO and the WRC
(A) Salmonella invasion by macropinocytosis into non-phagocytic HeLa cells expressing a control vector or the vector encoding wild-type EspG (espGWT) or a
mutant in binding both Arf and PAK (espGDADP). Values for invasion were normalized to the control
(B) THP1 phagocytosis of EPECDespG (DespG) in the presence of inhibitors of ARNO (secinh3) or macropinocytosis (eipa). Asterisks indicate a significant
difference from control (black bars). Not significant (ns). See also Figure S3C.
(C) Imaging of phagocytosed EPECDespG (DespG) bacteria (red) and THP1 actin cytoskeleton (green) from experiment in (B). Scale bars, 4 mm.
(D) WRC-dependent actin assembly via membrane-anchored Arf6GTPgS (depicted in cartoon) in cell-free extract alone or in extract containing recombinant ARNO
in the presence or absence of recombinant EspG derivatives described in (A).
(E) Immunoblotting of proteins recruited from cell extract by phosphatidylcholine:phosphatidylinositol (PCPI) membranes anchored with Arf6GTPgS in the
presence of ARNO and EspG derivatives described in (A).
(F) The interaction of PC membranes alone (left) or membranes anchored with GTPgS-loaded Arf6 with His-ARNO (red arrow) or GST-EspG (green arrow) alone,
or both in combination, in buffer. Asterisks indicate Arf6 dimers.
(G) Immunoblotting of samples from (A) with indicated antibodies against GST (EspG), ARNO, and Arf6 (right).
In bar charts (A) and (B), error bars represent ± SEM.tails (magnified inset) of8 mm relative to14 mm observed with
the control. Indeed, while Arf1QL and Rac1QL recruited both
EspG and GAT3 to the membrane (Figure 4C, GST), EspG but
not GAT3 impeded WRC recruitment (Figure 4C; Hem, Fig-
ure S3B, green arrows). It is not known how Arf1 activates the
WRC but the results suggested that EspG inhibits recruitment
of Arf1 effectors that bind switch 1. This hypothesis was further
substantiated by immunoblotting of the switch 1-binding protein
AP-1 (Austin et al., 2002; Ren et al., 2013) that was recruited in
the presence of GAT3 but not EspG (Figure 4C, AP-1).
EspG interaction with Arf1 is key to inhibiting WRC activa-
tion (Figure 2). Thus, we set out to resolve the molecular
basis of EspG interference further by purifying an array of Arf1QL702 Cell Reports 17, 697–707, October 11, 2016derivatives incorporating mutations within the alpha-1 helix
(Y35Q), switch 1 (T45I, I49T), or switch 2 (I74T, Y81H) domain
(Figure 4A), which have been implicated in interactions with
EspG or its cellular effectors (Selyunin et al., 2011; Kuai et al.,
2000). We examined EspG and GAT3 interactions with PC:PI mi-
crospheres anchored with each Arf1QL mutant derivative in
buffer (Figures 3D and 3E, and comprehensively shown in Fig-
ures S3B and S3C). EspG bound control Arf1QL but interaction
with anchored Arf1QL-Y35Q was completely abolished and
though the effector was still recruited by Arf1QL-I49T, the interac-
tion was evidently weaker (Figure 3D). The remaining Arf1 muta-
tions had no effect. In contrast, GAT3 bound each Arf1QL variant
equivalently except the switch 2 mutant Arf1QL-I74T (Figure 3E).
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Figure 4. Molecular Basis of WRC Interference by EspG
(A) Cartoon depicting Arf1 interaction with EspG or GAT3 of GGA3 with key residues and domains in Arf1 shown.
(B) WRC-dependent actin-based motility directed by Arf1QL and Rac1QL in extract alone (control), or with GAT3 or EspG. Insets magnify actin-comet tails. Scale
bars 5 mm.
(C) Immunoblotting of proteins recruited by membrane-anchored Arf1QL and Rac1QL from extract alone (ctrl), or from extract containing EspG or GAT3, or both in
combination. Anti-GST antibodies detected GAT3 and EspG.
(D) Interaction of EspG with PCPI membranes alone (–) or with membranes anchored with Arf1QL (ctrl) or Arf1QL derivatives containing indicated mutations.
(E) Experiment performed as (B) with GAT3.
See also Figure S3.EspG Targets Arf1 Residues Essential to Cooperation
with Rac1 and WRC Activation
As the Arf1 residue Y35, and to a lesser extent I49, likely underlie
EspG inhibition of the Arf1-Rac1-WRC axis, we next examined
whether these sites in Arf1 were key for collaboration with
Rac1 in WRC recruitment and activation at the membrane. In
contrast to Arf1QL or Rac1QL alone, only membranes co-
anchored with both GTPases (ctrl) triggered recruitment of the
WRC (Figures 5A and 5B) and robust actin comet tail formation
(Figures 5C and S4A) demonstrating that small GTPase cooper-
ationwas required forWRCactivation. Interestingly, Arf1QL alone
recruited AP-1 (Figure 5B), a marker for classical Arf1 effectors
that binds the alpha-1 helix and switch 1 domain of Arf1 (Austin
et al., 2002; Ren et al., 2013). However, when Arf1QL combined
with Rac1QL (ctrl) the presence of AP-1 was diminished relative
to Arf1QL alone, while WRC recruitment was enhanced uncover-
ing a remarkable switch in effector interplay by Arf1 when collab-
orating with Rac1 (Figure 5B). Thus, when working in synergy
with Rac1 the results indicate that Arf1 recruits and activates
the WRC via its alpha-1 helix and switch 1 domain in place of
classical effectors such as AP-1.
When we examined the Arf1QL derivatives mutated in the
alpha-1 helix, switch-1 or switch-2 domain, they all collaborated
with Rac1 by recruiting the WRC (Figures 5A and 5B andcomprehensively shown in Figures S4C and S4D). Given this
observation, we were surprised to find that certain Arf1 muta-
tions had a substantial impairment in WRC activation (Figures
5C and S4B). Like Arf1QL, mutants Arf1QL-T45I, -I74T, and
-Y81H formed robust actin comet tails (exemplified by I74Tin
Figure 5C). In contrast, the motility of membranes anchored
with Arf1QL-Y35Q or -I49T was markedly impaired (Figure 5C).
We noticed that a small proportion of actin shells (10%) sur-
rounding the Arf1QL-Y35Q and Arf1QL-I49T membranes broke
symmetry to form stumpy comet tails of 2 mm (exemplified by
green arrows in Figure 5C), indicating weak activation of the
WRC. We speculated that the weak activation of the WRC by
Arf1QL-Y35Q would be resistant to interference by EspG, which
binds Y35 (Figure 4D). Sure enough, while EspG blocked the
formation of comet tails generated by the switch 2 mutant
Arf1QL-I74T, stumpy comets were still formed by Arf1QL-Y35Q
even in the presence of EspG (Figure 5C).
Finally, as both Arf1 residues Y35 and I49mediated interaction
with EspG (Figure 4D), we examinedWRC recruitment and actin-
based motility at membranes anchored with a double mutant
(Figures 5A–5C). Arf1QL-Y35Q/I49T was incapable of collabo-
rating with Rac1QL as the WRC was neither recruited (Figures
5A and 5B) nor activated (Figure 5C). Thus, EspG targets specific
residues in the alpha-1 helix and switch 1 domain of Arf1 thatCell Reports 17, 697–707, October 11, 2016 703
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Figure 5. EspG Targets Arf1 Residues Essential to Synergy with Rac1 and WRC Activation
(A) WRC-dependent actin-based motility directed by Rac1QL alone (–) or in combination with Arf1QL (ctrl) or in combination with Arf1QL containing indicated
mutations. Insets magnify actin-comet tails. Scale bars, 5 mm.
(B) Proteins recruited by membrane-anchored Arf1QL or Rac1QL alone or Rac1QL in combination with Arf1QL containing indicated mutations as (A). Green arrows
indicate cyfip and Hem.
(C) Immunoblotting of samples from (B) with indicated antibodies (right).
(D) WRC-dependent actin-based motility directed by Rac1QL in combination with indicated Arf1QL mutants in extract containing EspG. Insets magnify actin-
comet tails. Scale bars, 5 mm.
See also Figure S4.facilitate small GTPase co-operation and actin filament poly-
merization by the WRC.
DISCUSSION
To avoid phagocytosis bacterial pathogens employ a wide
range of strategies. For example, many pathogens secrete
immunoglobulin proteases to cleave antibodies and impede
FcR-mediated uptake (Sarantis and Grinstein, 2012). However,
not all phagocytic mechanisms are driven by opsonization
emphasizing the need for other inventive virulence strategies.
We show that EPEC and EHEC circumnavigate this problem
by inhibiting WRC signaling to the actin cytoskeleton whose re-
modeling is at the very center of phagocytosis. The role of Rac1
and Arf6 in phagocytosis is well established (Niedergang et al.,
2003; Zhang et al., 1998; Caron and Hall, 1998), yet the contri-
bution of the WRC (Park et al., 2008) and Arf1 is less clear (Bee-
miller et al., 2006; Sendide et al., 2005). WRC activation by
Arf1 and Rac1 is known to mediate lamellipodia formation
and Salmonella macropinocytosis into host cells (Humphreys
et al., 2012a, 2013). Here, we show a crucial role for the
WRC in pathogen phagocytosis and establish that collabo-704 Cell Reports 17, 697–707, October 11, 2016rating WRC activators Arf1 and Rac1 are required. Structural
homologs cyfip and Hem of WRC are thought to oppose the
plasma membrane where small GTPases are anchored (Chen
et al., 2010). As Rac1 is known to bind cyfip (Kobayashi
et al., 1998), it is possible that Arf1 collaborates with Rac1 by
binding Hem (depicted in Figure 6) or through an unidentified
Arf1 effector acting as an intermediate. By using EspG to probe
the relationship between Arf1 and Rac1, we identify key resi-
dues in the Arf1 alpha-1 helix (Y31) and switch-1 domain (I49)
that underpin its collaboration with Rac1 in WRC recruitment
and activation at the membrane. Interestingly, we found that
the equivalent residues in Arf6 (Y31 and V45) were dispensable
for Arf6 activation of ARNO (Figure S5), and, although the EspG
interactions with Arf6-Y31Q were attenuated as previously re-
ported (Selyunin et al., 2011), the interactions at the membrane
were sufficient to block ARNO-dependent signaling to the WRC
mediated by either Arf6-Y31Q or Arf6-V45A (Figure S5). Thus,
the sites on Arf6 that permit signaling to ARNO and interference
by EspG are distinct from those in Arf1 that cooperate with
Rac1 in WRC signaling at the membrane, and perhaps reflect
differences in the primary sequence of Arf1 and Arf6 (70%
identity).
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Figure 6. Model for EspG Incapacitation of the WRC
(A) Arf6 recruits and activates ARNO that activates Arf1 which consequently
anchors via its exposedmyristoylationmoiety to the plasmamembrane (brown
lines). While the Arf1 binding partner remains speculative (e.g., Hem), never-
theless, membrane anchored active Arf1 and Rac1 work in synergy to recruit
and activate the WRC (i.e., release of the WAVE veroprolin homology cofilin
hemology acidic region [VCA] domain) that induces Arp2/3-dependent poly-
merization of actin filaments (red) and pathogen phagocytosis. Empty (GDP)
and filled blue (GTP) circles.
(B) EspG interaction with Arf GTPases blocks actin polymerization via a dual
mechanism: EspG impedes Arf6-activation of ARNO and Arf1-activation of the
WRC (highlighted by the red cross).Given the central role of RhoGTPases in phagocytosis, it is not
surprising that many pathogens employ GAPs to deactivate
GTPases (e.g., Yersinia YopE, Pseudomonas ExoS) (Black and
Bliska, 2000; Goehring et al., 1999). Yet, EPEC and EHEC
encode no known GAPs. Instead, the pathogens interfere with
Rho GTPase activation through EspH that binds Rho Dbl-family
GEFs to disrupt interaction with Rho GTPases (Dong et al.,
2010). Here, we show that EPEC and EHEC disarm professional
phagocytes through EspG that targets active Arf GTPases to
block activation of ARNO and the WRC. EspG is known to steri-
cally hinder Arf interactions with Arf GAPs and certain cellular
effectors (Selyunin et al., 2011, 2014). Consistent with this
view, we propose that EspG utilizes steric hindrance to prevent
Arf GTPase cooperation with Rac1 in driving cytoskeleton re-
modeling. Thus, EPEC and EHEC likely inhibit WRC-dependent
phagocytosis by nullifying both Rho activation via EspH and
Arf signaling via EspG.
The study also shows that ARNO, a plasma membrane GEF of
Arf1, operates in this phagocytic pathway, which is consistent
with a previously reported role for Arf1 and the ARNO homologcytohesin-1 in opsonin-dependent phagocytosis (Beemiller
et al., 2006; Sendide et al., 2005). ARNO is activated at the
plasma membrane by Arf6 (Stalder et al., 2011; Cohen et al.,
2007), a long established regulator of phagocytosis (Niedergang
et al., 2003; Zhang et al., 1998). EspG directly abrogated Arf6
recruitment and activation of ARNO thereby impeding Arf1 acti-
vation and describing a role for the Arf6-EspG interaction.
In summary, by targeting both Arf6 and Arf1 our work estab-
lishes a dual mechanism by which a single virulence effector un-
couples two arms of the WRC regulatory pathway and ultimately
inhibits phagocytic uptake to evade innate host defenses
(depicted in our model in Figure 6).
EXPERIMENTAL PROCEDURES
Bacterial Strains
EPEC E2348/69 and EHEC EDL933 (TUV93-0 Shiga toxin deficient derivative)
strains were used. Isogenic mutant EPEC DespG1/ DespG2 (Prof. Feng Shao)
and EHEC DespG (Dr. Ken Campellone) were kind gifts. For infections, bacte-
ria were cultured as previously described (Smith et al., 2010).
Plasmids
The following plasmids were generated by Invitrogen Gateway methodology:
pET15b-espG, pGEX2T-espG, pcDNA-HA-espG (encoding effector domain
residues 48–398) and pTrc99FA-espG (full length). Plasmids pET20b-
Arf1, pET20b-Arf6, pET15b-Rac1, pGEX2T-ARNO-2G, and pGEX2T-GGA3-
GAT1–313 were described previously (Humphreys et al., 2013). Point mutations
were introduced by site-directed mutagenesis into pET15b-espG, pGEX2T-
espG (EspGDP residues D205A, R208A; EspGDR Q293A; EspGDADP I152S,
P351A, P355A), pET20b-Arf1 or pET20b-Arf6 (mutations indicated in the
text). GST- and His-tagged proteins were expressed in E. coli Rosetta (Nova-
gen) at 16C before affinity purification (Humphreys et al., 2012b).
Antibodies
Antibodies were purchased from Abcam (Rac1, ab33186; Arf1, ab58578; Arf6,
ab81650; ARNO, ab56510; PAK1, ab154284), Sigma (Abi1, A5106; Actin,
A2066; Cyfip, P0092; Nap1, N3788; AP1, A4200), GE Healthcare Life Sciences
(GST, 27457701), QIAGEN (His, 34660) or were raised against recombinant
peptides in rabbits by Diagnostics Scotland (WAVE2, amino acids 180–241).
Antibodies against GST or His were used to detect EspG.
Mammalian Cell Culture and Transfection
The humanmonocyte-like cell line THP1s (kind gift from Prof. Gordon Dougan)
and mouse macrophage-like RAW264.7 (ATCC-TIB71) cells were cultured
(37C, 5% CO2) in RPMI-1640 or DMEM in the case of HeLa cells (ATCC-
CCL-2) supplemented with 2 mM L-glutamine, 10% heat-inactivated fetal
calf serum (FCS), 200 mg/mL–1 streptomycin, and 100 U mL–1 penicillin
(Schwende et al., 1996). THP1s were differentiated into mature macro-
phage-like cells by stimulation with 100 ng/mL Phorbol 12-myristate 13-acae-
tate (PMA) for 3 days and then cultured for an additional day without PMA
before phagocytosis assays.
Transient transfection of HeLa cells by microporation was performed using
the Neon Transfection System according to the manufacturer’s instructions
(Invitrogen). For RNA interference, small interfering RNA (siRNA) smart pools
against Arf1, Rac1, and Hem-1 or non-targeting control siRNA from Dharma-
con (GEHealthcare Life Sciences) were transfected into THP1 cells with Oligo-
fectamine transfection reagent (Invitrogen) according to manufacturer’s in-
structions. Transfection mixture was replaced after 24 hr with complete
growth medium and cells cultured 72 hr in total.
Phagocytosis Assays
Prior to infection EPEC and EHEC strains were harvested by centrifugation,
washed in phosphate-buffered saline (PBS) then incubated with pH-Rodo
(Thermo Fisher Scientific) before washing with Tris (pH 7.4)-buffered saline.
Approximately 2 3 105 mammalian cells seeded onto glass coverslips wereCell Reports 17, 697–707, October 11, 2016 705
infected with pH-Rodo-labeled bacteria (1 hr, 37C, 5% CO2) before washing
with PBS and fixation using 4% paraformaldehyde. Fixed cells were incubated
with rabbit anti-intimin (EPEC/EHEC outer membrane protein) antibodies,
washed with PBS, and then incubated with anti-rabbit Alexa Flour 350 anti-
bodies and cells visualized phalloidin-FITC-488 (Thermo Fisher Scientific) in
PBS supplemented with Tx100. Phagocytosis was quantified by counting
the number of extracellular bacteria labeled with intimin antibodies relative
to intracellular bacteria showing pH-Rodo fluorescence using automated
Volocity software (Improvision). When appropriate, cells were incubated with
25 mMSecinh3 (Merck). Immunofluorescence microscopy and images assem-
bled as described (Humphreys et al., 2012b). All experiments were performed
at least three times.
Salmonella Invasion of Non-phagocytic Host Cells
Wild-type Salmonella enterica serovar Typhimurium SL1344 were used to
assay invasion into non-phagocytic cells as previously described (Humphreys
et al., 2013).Salmonella encoding pM975 that expresses GFP via the SPI2 pro-
moter when bacteria are within Salmonella containing vacuoles (SCVs)
(Schlumberger et al., 2007) were used to infect HeLa cells (10 min), and the
number of fluorescent bacteria was counted per cell microscopically.
In Vitro WRC-Dependent Actin-Based Motility
Preparation of porcine brain extract, actin-based motility by phospholipid-
coated beads, and isolation of bead membrane-associated proteins have
been described in detail (Hume et al., 2014). When indicated, extract or buffer
containing recombinant EspG derivatives, GAT3, or ARNO was used. Quanti-
fication of comet tail length was performed on 50 comet tails per experiment
using Volocity measurement software (Improvision). All experiments were per-
formed at least three times.
Statistics
All experiments were performed at least three times. Geometric means were
calculated, and significance was determined by Student’s t test or one-way
ANOVA followed by a post hoc Dunnett’s comparison. *p < 0.05 was consid-
ered significant.
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